Janus Henderson Group
CMTA

Janus Henderson Group’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Janus Henderson Group’s Portfolio CMTA Stock Details CMTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,050,389
Closed -$53.5M – 1437
2019
Q1 		$53.5M Sell
2,050,389
-54,651
-3% -$1.02M 0.03% 558
2018
Q4 		$24.8M Buy
2,105,040
+373,848
+22% +$4.65M 0.02% 696
2018
Q3 		$19.3M Sell
1,731,192
-15,104
-0.9% -$159K 0.01% 828
2018
Q2 		$23M Sell
1,746,296
-13,112
-0.7% -$212K 0.01% 771
2018
Q1 		$26.7M Buy
1,759,408
+646,459
+58% +$10.5M 0.02% 720
2017
Q4 		$21.1M Buy
1,112,949
+353,157
+46% +$5.91M 0.01% 756
2017
Q3 		$12.8M Buy
+759,792
New +$12.4M 0.01% 815

Janus Henderson Group's CMTA Position: Q2 2019 in Review

Janus Henderson Group sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 2,050,389 shares — an estimated $53.5M sold.

Janus Henderson Group first reported a position in CMTA in Q3 2017 and held it in 7 quarters. The position peaked at $53.5M in Q1 2019. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

  • Janus Henderson Group reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
  • Janus Henderson Group sold 2,050,389 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $53.5M.
  • Janus Henderson Group first reported a position in Clementia Pharmaceuticals Inc. in Q3 2017 and held it in 7 quarters.
  • Janus Henderson Group's Clementia Pharmaceuticals Inc. position peaked at $53.5M in Q1 2019.
  • 0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Janus Henderson Group's 13F filing for Q2 2019, filed 31 Jul 2019.